AI blood test could spare breast cancer patients unnecessary chemotherapy
NCT ID NCT04874064
Summary
This study aims to develop a new blood test using artificial intelligence to help doctors better treat triple-negative breast cancer. Researchers will analyze tiny particles in the blood and tumor tissue from 130 patients to create a test that can predict how well chemotherapy is working. The goal is to identify which patients truly need extra chemotherapy after surgery and which can avoid it, sparing them from unnecessary side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Jewish General Hospital
RECRUITINGMontreal, Quebec, H3T 1E1, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
St. Joseph's Health Care London
RECRUITINGLondon, Ontario, N6A 4V2, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The Ottawa Hospital Cancer Center
RECRUITINGOttawa, Ontario, K1H 8L6, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.